Malignant neoplasm of unspecified testis, unspecified whether descended or undescended
ICD-10 C62.90 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified testis, unspecified whether descended or undescended.
C62.90 refers to a malignant neoplasm of the testis that is not specified as either descended or undescended. Testicular cancer is a relatively rare malignancy that primarily affects younger males, typically between the ages of 15 and 35. The condition can arise from germ cells, which are responsible for sperm production, or from non-germ cell tissues. Symptoms may include a lump in the testicle, swelling, or discomfort. Diagnosis is often confirmed through imaging studies and biopsy. The staging of testicular cancer is crucial for determining the appropriate treatment plan and prognosis, with stages ranging from localized disease to advanced metastatic disease. PSA levels are not typically used for testicular cancer, as they are more relevant for prostate cancer. Fertility considerations are significant, as treatment may impact sperm production and fertility, necessitating discussions about sperm banking prior to treatment. Accurate coding is essential for proper treatment planning and insurance reimbursement.
Detailed clinical notes on the patient's history, physical examination findings, imaging results, and biopsy reports.
Diagnosis and management of testicular masses, follow-up after orchiectomy, and fertility preservation discussions.
Urologists must document the specific type of testicular cancer and any fertility implications.
Comprehensive treatment plans, staging information, and follow-up care details.
Chemotherapy regimens for testicular cancer, management of metastatic disease, and survivorship care.
Oncologists should ensure that staging and treatment response are clearly documented.
Used when a patient undergoes surgical removal of the testis due to malignancy.
Operative report detailing the procedure and findings.
Urologists must document the indication for surgery and any findings during the procedure.
The descent of the testis is clinically significant as undescended testis is associated with a higher risk of malignancy. Accurate documentation helps in treatment planning and risk assessment.
